<DOC>
	<DOCNO>NCT00001823</DOCNO>
	<brief_summary>Background : The NCI Surgery Branch develop experimental therapy involve take white blood cell patient ' tumor blood , grow laboratory large number , give cell back patient . Objective : This study allow patient screen evaluation participation NCI Surgery Branch Protocols Eligibility : Patients must meet minimum eligibility criterion NCI surgery Branch Treatment Protocol Design Patients undergo test evaluation require appropriate NCI Surgery Branch Treatment protocol</brief_summary>
	<brief_title>Evaluation NCI Surgery Branch Clinical Studies</brief_title>
	<detailed_description>Background : Potential research candidate undergo thorough screen include laboratory test , scan , x-rays review pathology slide determine initial eligibility Surgery Branch research protocol . Objectives : To permit evaluation patient refer NCI Surgery Branch order identify individual suitable candidate Surgery Branch clinical research protocol . To assess frequency HLA type expression neo antigens malignant tumor across population cancer patient undergo screen NCI Surgery Branch Protocols . Eligibility : Patient suspect , biopsy proven malignant disease . Patient , parent guardian ( minor ) , able provide inform consent . Design : Patients enrol protocol evaluate NCI Surgery Branch physicians determine individual 's suitability participation clinical research protocol . An accrual ceiling 6000 patient set meet screening need Surgery Branch .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients suspect , biopsy proven malignant disease . Patient , legal guardian ( patient le 18 year age ) , able provide inform consent . EXCLUSION CRITERIA :</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 6, 2017</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Gene Therapy</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Melanoma</keyword>
	<keyword>Clinical Trial</keyword>
</DOC>